William Blair Research Analysts Lift Earnings Estimates for GoHealth, Inc. (NASDAQ:GOCO)

GoHealth, Inc. (NASDAQ:GOCOGet Rating) – William Blair boosted their Q4 2022 earnings per share estimates for shares of GoHealth in a report released on Wednesday, May 11th. William Blair analyst A. Klauber now anticipates that the company will earn $0.32 per share for the quarter, up from their previous estimate of $0.25.

Several other research analysts also recently weighed in on the stock. Royal Bank of Canada downgraded shares of GoHealth from an “outperform” rating to a “sector perform” rating and dropped their target price for the stock from $10.00 to $2.00 in a report on Thursday, March 3rd. Truist Financial downgraded shares of GoHealth from a “buy” rating to a “hold” rating and set a $2.00 price objective for the company. in a report on Wednesday, March 2nd. Credit Suisse Group dropped their price objective on shares of GoHealth from $3.00 to $1.50 in a report on Thursday, March 17th. Zacks Investment Research downgraded shares of GoHealth from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, Evercore ISI dropped their price objective on shares of GoHealth from $4.50 to $1.75 and set an “in-line” rating for the company in a report on Wednesday, March 16th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $4.64.

Shares of GoHealth stock opened at $0.69 on Friday. The company has a market capitalization of $221.68 million, a P/E ratio of -0.39 and a beta of 1.27. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.98 and a current ratio of 1.98. The company has a fifty day moving average of $1.06 and a 200 day moving average of $2.49. GoHealth has a fifty-two week low of $0.63 and a fifty-two week high of $12.12.

GoHealth (NASDAQ:GOCOGet Rating) last issued its earnings results on Tuesday, March 15th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $1.43. The company had revenue of $449.60 million during the quarter, compared to the consensus estimate of $480.61 million. GoHealth had a negative net margin of 17.78% and a positive return on equity of 9.57%. GoHealth’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 EPS.

Institutional investors have recently modified their holdings of the company. FNY Investment Advisers LLC purchased a new stake in shares of GoHealth in the fourth quarter valued at approximately $27,000. Flputnam Investment Management Co. acquired a new stake in shares of GoHealth in the 1st quarter worth $27,000. Ausdal Financial Partners Inc. purchased a new position in shares of GoHealth during the 4th quarter worth $39,000. Teacher Retirement System of Texas acquired a new position in shares of GoHealth during the 4th quarter valued at about $42,000. Finally, Sciencast Management LP purchased a new stake in shares of GoHealth in the first quarter valued at about $44,000. Institutional investors and hedge funds own 41.94% of the company’s stock.

About GoHealth (Get Rating)

GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Featured Stories

Earnings History and Estimates for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.